Dr. Mark James Fussa, DO

Dr. Fussa practices at Jefferson Stratford Hospital in Stratford, New Jersey, part of Thomas Jefferson University.

Dr. Fussa's NPI, 1942407374, was assigned on June 29, 2007. Dr. Fussa graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2003. Dr. Fussa holds New Jersey license 25MB08120000.

Dr. Fussa's primary practice is Jefferson Stratford Hospital, at 18 East Laurel Road, Stratford, NJ 08084 in Camden County. The practice phone is (856) 346-7802.

Dr. Fussa's primary practice is Jefferson Stratford Hospital in Stratford, New Jersey, part of Thomas Jefferson University. Dr. Fussa is also affiliated with Cooper University Hospital. The medical group on file is Jefferson Health. Dmand AI also links Dr. Fussa to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fussa practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Fussa's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Fussa is board certified in infectious disease by the American Board of Internal Medicine. Dr. Fussa is licensed in New Jersey.

Dmand AI lists acute skin infection, hiv/aids, immune deficiency disease, joint or bone infection, lyme disease, pneumonia, UTI and yeast infection among the conditions Dr. Fussa treats.

CMS data shows 869 Medicare services from Dr. Fussa across 8 procedure codes in 2024, for 469 Medicare patients. Medicare paid $74,744 for them.

CMS counts 469 Medicare patients who saw Dr. Fussa in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fussa's median patient age at 66, with 46% women.

In 2024, Dr. Fussa wrote 2,049 Medicare Part D claims for 123 patients. 69% of them were for generic drugs. CMS names the drug for 1,662 of them, across 61 drugs with 11 or more claims each, at $1,801,239 in total drug cost. In 2023, CMS named 1,573 claims across 63 drugs.

Dr. Fussa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fussa as offering telehealth.

Dmand AI links 1 paper to Dr. Fussa. Dr. Fussa's most frequent co-author is Joseph Stephen Demidovich, DO.

CMS Open Payments shows 16 general payments to Dr. Fussa from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. ViiV Healthcare Company paid the most, $154.

Dr. Fussa graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2003. Dr. Fussa is a member of AOA.

Dr. Fussa is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.